非致命性甲唑酰胺诱导的再生障碍性贫血。

Nonfatal methazolamide-induced aplastic anemia.

作者信息

Gangitano J L, Foster S H, Contro R M

出版信息

Am J Ophthalmol. 1978 Jul;86(1):138-9. doi: 10.1016/0002-9394(78)90032-6.

Abstract

An 83-year-old man developed nonfatal aplastic anemia after taking methazolamide for three months. We made a diagnosis of methazolamide-induced aplastic anemia, discontinued all medication, gave the patient platelet and red blood cell transfusions, and treated him with oxymetholone. Approximately four months after initiation of treatment, the patient felt well, and he is currently receiving packed red blood cell transfusions every three weeks.

摘要

一名83岁男性在服用醋甲唑胺三个月后发生非致命性再生障碍性贫血。我们诊断为醋甲唑胺诱发的再生障碍性贫血，停用所有药物，给予患者血小板和红细胞输注，并使用羟甲烯龙进行治疗。治疗开始约四个月后，患者感觉良好，目前每三周接受一次浓缩红细胞输注。